Skip to main content

The Center for Translational Neuroscience


The Center for Translational Neuroscience aims to be a center for disruptive innovation in the neuroscience area that improves quality of life, treats or even cures disease. Diseases of the brain and nervous system leave people suffering chronically for long periods of time, sometimes for life. We collaboratively discover and develop therapeutics for CNS disorders and help entrepreneurs with innovative ideas to develop them into viable enterprises through provision of coaching, consulting, and providing incubator space.

About Us

ILSE has a Center for Translational Neuroscience (CTN) to address grand challenges in CNS and related diseases. In recent years, the pharmaceutical industry has divested significant R&D resources from CNS product development due in large part to the lack of productivity in the pipeline. In addition, large cuts in workforce across biopharma have left behind an enormous talent base of scientists and clinicians. ILSE aims to be a nexus of research and entrepreneurship to create next generation technologies for this space.

ILSE engaged various stakeholders in neurosciences, including scientists and researchers, clinicians, the investment community, foundations and patient advocacy groups, and pharmaceutical business development executives, to understand key issues limiting investment in neuroscience. Due to the lack of biomarkers, diagnostics and companion diagnostics, and predictive models, the risk profile for drug development is simply too high. Accordingly, our strategy is to focus on these areas to create new tools and resources that we believe will compel future investments into new companies and technologies and ultimately provide novel modalities to treat CNS and related disorders.

Building off of ILSE’s strong legacy of microbiology, microbial genetics, microbiome, bioinformatics, immunology and inflammation research, we believe that we can pioneer and innovate the next generation of translational research discoveries where these distinct arenas converge.

ILSE is currently seeking collaborators across various scientific research fields. We will continue to build our existing network of researchers to identify and source technologies, projects and funding sources. ILSE aims to provide an administrative structure to support innovation projects and teams, to write grants and where possible, to provide seed funding.



  • Neurodegenerative diseases
  • Neurodevelopmental disorders

Member Companies

  • Synubi
  • Plumeria
  • Others

Contact Us

For more information about the Center contact: Sam Kongsamut, PhD